dc.contributor.author | Andersen, Sarah Hjorth | |
dc.contributor.author | Lupattelli, Angela | |
dc.contributor.author | Handal, Marte | |
dc.contributor.author | Spigset, Olav | |
dc.contributor.author | Ystrøm, Eivind | |
dc.contributor.author | Nordeng, Hedvig Marie Egeland | |
dc.date.accessioned | 2022-08-01T07:59:03Z | |
dc.date.available | 2022-08-01T07:59:03Z | |
dc.date.created | 2021-10-01T01:16:06Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Pharmacoepidemiology and Drug Safety. 2021, 30 (10), 1380-1390. | |
dc.identifier.issn | 1053-8569 | |
dc.identifier.uri | https://hdl.handle.net/11250/3009460 | |
dc.language.iso | eng | |
dc.title | Prenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder - a Follow-Up Study in the Norwegian Mother, Father and Child Cohort | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1380-1390 | |
dc.source.volume | 30 | |
dc.source.journal | Pharmacoepidemiology and Drug Safety | |
dc.source.issue | 10 | |
dc.identifier.doi | 10.1002/pds.5250 | |
dc.identifier.cristin | 1941779 | |
dc.relation.project | Norges forskningsråd: 288083 | |
dc.relation.project | Norges forskningsråd: 262177 | |
dc.relation.project | EU/639377 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |